Simultaneous improvement of minimal-change nephrotic syndrome and anemia with steroid therapy

Nephron

Volumn 81, Issue 1, 1999, Pages 84-88

  Yabana, Machiko ^a   Kihara, Minoru ^a   Toya, Yoshiyuki ^a   Tamura, Kouichi ^a   Matsumoto, Katsumi ^a   Takagi, Nobuyoshi ^a   Kamijo, Seiko ^b   Ishii, Masao ^a   Umemura, Satoshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Anemia; Erythropoietin; Minimal change nephrotic syndrome

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; PREDNISOLONE; PROTEIN; STEROID;

ADULT; ANEMIA; ARTICLE; BIOSYNTHESIS; BLOOD LEVEL; CASE REPORT; DISEASE COURSE; HEMODILUTION; HUMAN; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STEROID THERAPY; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION;

ANEMIA; ANTI-INFLAMMATORY AGENTS; ERYTHROPOIETIN; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; PREDNISOLONE; PROTEINURIA;

EID: 0032892421     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045252     Document Type: Article

References (18)

1. Vaziri ND, Kaupke CJ, Barton CH, Gonzales E: Plasma concentration and urinary excretion of erythropoietin in adult nephrotic syndrome. Am J Med 1992;92:35-40.
2. Zhou X-J, Vaziri ND: Erythropoietin metabolism and pharmacokinetics in experimental nephrosis. Am J Physiol 1992;263:F812-F815.
3. Eckardt K-U, Kurtz A, Bauer C: Regulation of erythropoietin production is related to proximal tubular function. Am J Physiol 1989;256: F942-F947.
4. Maxwell PH, Ferguson DJP, Nicholls LG, Iredale JP, Pugh CW, Johnson MH, Ratcliffe PJ: Sites of erythropoietin production. Kidney Int 1997;51:393-401.
5. 2-microglobulin excretion in primary nephrotic children. Nephron 1996;74: 401-404.
6. Ishimitsu T, Ono H, Sugiyama M, Asakawa H, Oka K, Numabe A, Abe M, Matsuoka H, Yagi S: Successful erythropoietin treatment for severe anemia in nephrotic syndrome without renal dysfunction. Nephron 1996;74:607-610.
7. Mees EJD, Roos JC, Boer P, Yoe OH, Simatupang TA: Observations on edema formation in the nephrotic syndrome in adults with minimal lesions. Am J Med 1979;67:378-384.
8. Inomata S, Itoh M, Imai H, Sato T: Serum levels of erythropoietin as a novel marker reflecting the severity of diabetic nephropathy. Nephron 1997;75:426-430.
9. Flaharty KK, Caro J, Erslev A, Whalen JJ, Morris EM, Björnsson TD, Vlasses PH, Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men. Clin Pharmacol Ther 1990;47:557-564.
10. Erslev AJ: Erythropoietin. N Engl J Med 1991; 324:1339-1344.
11. Gansevoort RT, Vaziri ND, de Jong PE: Treatment of anemia of nephrotic syndrome with recombinant erythropoietin. Am J Kidney Dis 1996;28:274-277.
12. Koshy MC, Kashgarian M, Boreyko C: Factor IX deficiency in nephrotic syndrome. Conn Med 1975;39:472-474.
13. Vaziri ND, Paule P, Toohey J, Hung E, Alikhani S, Darwish R, Paul MV: Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome. Arch Intern Med 1984;144:1802-1803.
14. Vaziri ND, Gonzales E, Barton CH, Chen HT, Nguyen Q, Arquilla M: Factor XIII and its substrates fibronectin, fibrinogen and alpha-2-antiplasmin in plasma and urine of patients with nephrosis. J Lab Clin Med 1991;117:152-156.
15. Afrasiabi MA, Vaziri ND, Gwinup G, Mays M, Barton CH, Ness R, Valenta LJ: Thyroid function studies in nephrotic syndrome. Ann Intern Med 1979;90:335-338.
16. Sato K, Gray R, Lemann J Jr: Urinary excretion of 25-hydroxyvitamin D in health and nephrotic syndrome. J Lab Clin Med 1982;99: 325-330.
17. Boyer SH, Bishop TR, Rogers OC, Noyes AN, Frelin LP, Hobbs S: Roles of erythropoietin, insulin-like growth factor 1, and unidentified serum factors in promoting maturation of purified murine erythroid colony-forming units. Blood 1992;80:2503-2512.
18. Vaziri ND: Endocrinological consequences of the nephrotic syndrome. Am J Nephrol 1993; 13:360-364.